ロード中...
Effects of denosumab versus teriparatide in glucocorticoid-induced osteoporosis patients with prior bisphosphonate treatment
INTRODUCTION: Osteoporosis is one of the serious adverse effects associated with glucocorticoid therapy. Although bisphosphonates have been used for glucocorticoid-induced osteoporosis (GIO), some patients have shown an inadequate response. In such cases, denosumab or teriparatide are used. However,...
保存先:
| 出版年: | Bone Rep |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7352055/ https://ncbi.nlm.nih.gov/pubmed/32676524 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bonr.2020.100293 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|